Safe Use of Hydrogen Perox Ideas a Nasal Spray - a Review
Main Article Content
Abstract
The present review aims to find out the possibility of using a H2O2 nasal spray by studying the available hydrogen peroxide sprays for human use for various purposes. Normally 3-6% solutions of H2O2 are used in medical applications. The reported NOEL and LOAEL studies indicated that up to 14.6mg/m3 was found to be safe in human trials. Hence the available safety reports recommend that, a single exposure of 0.3% H2O2 in the external nostrils as a nasal wash with a subsequent blowing of nose can be helpful in relieving decongestion.
References
Keke Z., Xuedong Z., Xin X. The origin of hydrogen peroxide in oral cavity and its role in oral microecology balance. Hua Xi Kou Qiang Yi Xue Za Zhi. 2017; 35:215–220.
Wang M., Lu M., Zhang C., Wu X., Chen J., Lv W. Oxidative stress modulates the expression of toll-like receptor 3 during respiratory syncytial virus infection in human lung epithelial A549 cells. Mol Med Rep. 2018.
To E.E., Broughton B.R.S., Hendricks K.S., Vlahos R., Selemidis S. Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages. Free Radic Res. 2014; 48:940–947.
Liu M., Chen F., Liu T., Chen F., Liu S., Yang J. The role of oxidative stress in influenza virus infection. Microbes Infect. 2017; 19:580–586.
Zobel S., Lorenz M., Frascaroli G., Böhnke J., Bilz N.C., Stanifer M.L., et al. Rubella virus strain-associated differences in the induction of oxidative stress are independent of their interferon activation. Viruses. 2018; 10.
Aizawa H., Koarai A., Shishikura Y., Yanagisawa S., Yamaya M., Sugiura H. Oxidative stress enhances the expression of IL-33 in human airway epithelial cells. Respir Res. 2018; 19:52.
Abd-Elghaffar A.A., Ali A.E., Boseila A.A., Amin M.A. Inactivation of rabies virus by hydrogen peroxide. Vaccine. 2016; 34:798–802.
Cusinato R., Pacenti M., Martello T., Fattori P., Morroni M., Palù G. Effectiveness of hydrogen peroxide and electron-beam irradiation treatment for removal and inactivation of viruses in equine-derived xenografts. J Virol Methods. 2016; 232:39–46.
Kalmar I.D., Cay A.B., Tignon M. Sensitivity of African swine fever virus (ASFV) to heat, alkalinity and peroxide treatment in presence or absence of porcine plasma. Vet Microbiol. 2018; 219:144–149.
Vannier M., Chewins J. Hydrogen peroxide vapour is an effective replacement for formaldehyde in a BSL-4 foot and mouth disease vaccine manufacturing facility. Lett Appl Microbiol. 2019; 69:237–245.
Ragland N.H., Miedel E.L., Engelman R.W. PCR prevalence of murine opportunistic microbes and their mitigation by using vaporized hydrogen peroxide. J Am Assoc Lab Anim Sci. 2019; 58:208–215.
Johnsen M.A. The influence of particle size. Spray Technology and Marketing. 2004; 14(11):24–27.
Rothe H. Special aspects of cosmetic spray safety evaluation. 2011.
Bremmer H.J., Prud’homme de Lodder L.C.H., van Engelen J.G.M. Cosmetics Fact Sheet: To assess the risks for the consumer. RIVM Report No. 320104001/2006.
Rothe H., Fautz R., Gerber E., et al. Special aspects of cosmetic spray safety evaluations: Principles on inhalation risk assessment. Toxicol Lett. 2011; 205(2):97–104.
National Center for Biotechnology Information. PubChem compound summary for CID 784, hydrogen peroxide. 2022.
Biocidal Products Committee. Regulation (EU) No 528/2012. Evaluation of active substances assessment report: Hydrogen peroxide. Finland; 2015.
European Chemicals Bureau. European Union Risk Assessment Report: Hydrogen peroxide. 2003.
ECETOC. Hydrogen peroxide OEL criteria document. Brussels; 1996.
Ito A., Watanabe H., Naito M., et al. Correlation between induction of duodenal tumor by hydrogen peroxide and catalase activity in mice. Gann. 1984; 75(1):17–21.
Halliwell B. Superoxide dismutase, catalase and glutathione peroxidase. New Phytologist. 1974; 73(6):1075–1086.
Halliwell B., Gutteridge J. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984; 219(1):1–14.
Ernstgård L., Sjögren B., Johanson G. Acute effects of exposure to vapors of hydrogen peroxide in humans. Toxicol Lett. 2012; 212(2):222–227.
NICNAS. Human health Tier II assessment for hydrogen peroxide (H2O2). Sydney, Australia.
Oberst F., Comstock C., Hackley E. Inhalation toxicity of ninety percent hydrogen peroxide vapor. A.M.A. Arch Ind Health. 1954; 10(4):319–327.
National Institutes of Health. Open Chemistry Database; hydrogen peroxide.
IARC. Hydrogen peroxide. IARC Monographs. 1999; 71:671–689.
ATSDR. Hydrogen peroxide (H2O2). Atlanta, GA; 2017.
NIOSH. IDLH values table. Washington, DC; 2014.
SCOEL. Recommendation for hydrogen peroxide exposure limits. Brussels; 2008.
NICNAS. Human health Tier II assessment for hydrogen peroxide (H2O2). Updated 2014.
William V., Robertson B., Ropes M.W., et al. The degradation of mucins by ascorbic acid and hydrogen peroxide. Biochem J. 1941; 35:903.
Mantle M. Effect of hydrogen peroxide on rat intestinal mucin. Biochem J. 1991; 274:679.
Cooper B., Creeth J.M., Donald A.S.R. Limited degradation of mucus glycoproteins. Biochem J. 1985; 228:615.
Pillai K., Akhter J., Chua T.C., Morris D.L. Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin. J Surg Res. 2012; 174(2):e69–e73.
Di Domênico M.B., Cesca H., Ponciano T.H.J., et al. Effectiveness of hydrogen peroxide as auxiliary treatment for hospitalized COVID-19 patients. Epidemiol Health. 2021; 43:e2021032.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.